Literature DB >> 20926384

Adenosine A2A receptor is involved in cell surface expression of A2B receptor.

Kengo Moriyama1, Michail V Sitkovsky.   

Abstract

The A2A and A2B adenosine receptors (A2AR and A2BR) are implicated in many physiological processes. However, the mechanisms of their intracellular maturation and trafficking are poorly understood. In comparative studies of A2AR versus A2BR expression in transfected cells, we noticed that the levels of cell surface expression of A2BR were significantly lower than those of A2AR. A large portion of the A2BR was degraded by the proteasome. Studies of cell surface expression of A2BR chimeric molecules in transfectants suggested that A2BR does not have the dominant forward transport signal for export from the endoplasmic reticulum to the cell surface. A2BR surface expression was increased in A2BR chimeras where the A2BR carboxyl terminus (CT) was replaced or fused with the A2AR CT. Co-transfection of A2AR with A2BR enhanced surface expression of A2BR though the F(X)(6)LL motif in the A2AR CT. The requirements of A2AR expression for better A2BR cell surface expression was not only established in transfectants but also confirmed by observations of much lower levels of A2BR-induced intracellular cAMP accumulation in response to A2BR-activating ligand in splenocytes from A2AR(-/-) mice than in wild type mice. The results of mechanistic studies suggested that poor A2BR expression at the cell surface might be accounted for mainly by the lack of a dominant forward transport signal from the endoplasmic reticulum to the plasma membrane; it is likely that A2BR forms a hetero-oligomer complex for better function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926384      PMCID: PMC2998132          DOI: 10.1074/jbc.M109.098293

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Efficient export of the vesicular stomatitis virus G protein from the endoplasmic reticulum requires a signal in the cytoplasmic tail that includes both tyrosine-based and di-acidic motifs.

Authors:  C S Sevier; O A Weisz; M Davis; C E Machamer
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 2.  G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease.

Authors:  Alfredo Ulloa-Aguirre; Jo Ann Janovick; Alfredo Leaños Miranda; P Michael Conn
Journal:  ACS Chem Biol       Date:  2006-11-21       Impact factor: 5.100

Review 3.  Seven transmembrane receptors: something old, something new.

Authors:  R J Lefkowitz
Journal:  Acta Physiol (Oxf)       Date:  2007-05       Impact factor: 6.311

Review 4.  G-protein-coupled receptors: an update.

Authors:  B B Fredholm; T Hökfelt; G Milligan
Journal:  Acta Physiol (Oxf)       Date:  2007-05       Impact factor: 6.311

5.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

6.  Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.

Authors:  J A Burrows; L K Willis; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Constitutive traffic of melanocortin-4 receptor in Neuro2A cells and immortalized hypothalamic neurons.

Authors:  Sameer Mohammad; Giovanna Baldini; Susana Granell; Paola Narducci; Alberto M Martelli; Giulia Baldini
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

8.  The A2b adenosine receptor protects against vascular injury.

Authors:  Dan Yang; Milka Koupenova; Donald J McCrann; Katherine J Kopeikina; Herbert M Kagan; Barbara M Schreiber; Katya Ravid
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205

9.  Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.

Authors:  Sébastien Granier; Samuel Kim; Aaron M Shafer; Venkata R P Ratnala; Juan José Fung; Richard N Zare; Brian Kobilka
Journal:  J Biol Chem       Date:  2007-03-08       Impact factor: 5.157

10.  VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.

Authors:  C M Lee; M M Hickey; C A Sanford; C G McGuire; C L Cowey; M C Simon; W K Rathmell
Journal:  Oncogene       Date:  2009-03-02       Impact factor: 9.867

View more
  37 in total

Review 1.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

2.  Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A3 adenosine receptors in cardiomyoyctes.

Authors:  Tina C Wan; Akihito Tampo; Wai-Meng Kwok; John A Auchampach
Journal:  Biochem Pharmacol       Date:  2019-01-30       Impact factor: 5.858

Review 3.  Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.

Authors:  Karen M Dwyer; Bellamkonda K Kishore; Simon C Robson
Journal:  Nat Rev Nephrol       Date:  2020-07-08       Impact factor: 28.314

Review 4.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

5.  Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-α release.

Authors:  Almut Grenz; Jae-Hwan Kim; Jessica D Bauerle; Eunyoung Tak; Holger K Eltzschig; Eric T Clambey
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

Review 6.  New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.

Authors:  Elizabeth A Vecchio; Jo-Anne Baltos; Anh T N Nguyen; Arthur Christopoulos; Paul J White; Lauren T May
Journal:  Br J Pharmacol       Date:  2018-06-21       Impact factor: 8.739

7.  Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.

Authors:  Shraddha Nayak; Md Abdul H Khan; Tina C Wan; Hong Pei; Joel Linden; Melinda R Dwinell; Aron M Geurts; John D Imig; John A Auchampach
Journal:  Purinergic Signal       Date:  2015-09-18       Impact factor: 3.765

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

9.  Spare Adenosine A2a Receptors Are Associated With Positive Exercise Stress Test In Coronary Artery Disease.

Authors:  Jean Ruf; Franck Paganelli; Laurent Bonello; Nathalie Kipson; Giovanna Mottola; Julien Fromonot; Jocelyne Condo; Alain Boussuges; Laurie Bruzzese; Françis Kerbaul; Yves Jammes; Vlad Gariboldi; Frédéric Franceschi; Emmanuel Fenouillet; Régis Guieu
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

Review 10.  Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics.

Authors:  Patrick M McNeely; Andrea N Naranjo; Anne S Robinson
Journal:  Biotechnol J       Date:  2012-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.